Microsoft Corporation (NASDAQ:MSFT) is one of the best software infrastructure stocks to invest in. On June 26, Antigen ...

Previously, due to the risk of cytokine release syndrome and neurological toxicities, many CAR T-cell therapies included a REMS requirement.

The Breyanzi REMS program and the Abecma REMS program were established due to the risk of cytokine release syndrome and neurologic toxicities.

The US Food and Drug Administration (FDA) announced that it has eliminated the Risk Evaluation and Mitigation Strategies (REMS) for currently approved BCMA- and CD19-directed autologous chimeric ...

Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...

The government stated the percentage of zero-dose children in India has actually declined to 0.06 per cent in 2024 from 0.11 ...

And for respiratory illnesses, the single antigen vaccines have never worked,” Kennedy said when asked by CBS’s chief medical correspondent, Jonathan LaPook, why the decision was delayed.

Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with ...

The prostate-specific antigen (PSA) test is used to measure blood PSA levels and help detect prostate cancer or other prostate abnormalities.

Researchers conducted a meta-analysis of 16 randomised clinical trials comparing inactivated high-dose (60 µg haemagglutinin antigen load per strain) and standard-dose (15 µg haemagglutinin antigen ...

Characterization of antigen-specific T cell responses typically is a critical constituent of these immunological investigations which can also aid in patient stratification for future trials. As a ...